Skip to content

Alto Neuroscience ANRO Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-38.9%+2.9pp-41.8%+3.2pp-45%-2.2pp-42.8%-4.7pp-38%
Return on assets-33.2%+1.8pp-34.9%+1.9pp-36.8%-0.3pp-36.5%-3.4pp-33.1%+13.4pp
Liquidity
Current ratio20.5×+4.8×15.7×+0.3×15.4×-3.0×18.4×-4.1×22.5×+5.6×
Quick ratio20.5×+4.8×15.7×+0.3×15.4×-3.0×18.4×-4.1×22.5×+5.6×
Cash ratio20.1×+4.5×15.6×+0.3×15.3×-2.9×18.2×-4.0×22.2×+5.4×
Leverage
Debt-to-equity0.1×-0.1×0.1×-0.1×0.2×0.0×0.2×0.0×0.2×+0.1×
Debt-to-assets0.1×0.0×0.1×-0.1×0.2×0.0×0.2×0.0×0.1×+0.1×
Interest coverage-32.2×-5.3×-26.9×+2.9×-29.8×+6.7×-36.5×+6.5×-43×+6.9×
Per Share
Book value per share$7.40+41.2%$5.24+27.3%$4.12-9.7%$4.56-11.4%$5.14-16.5%
Valuation
Market capitalization$874.19M+1,358%$552.98M+408%$108.85M+60.8%$67.68M+15.7%$58.48M-48.7%
Enterprise value$630.81M-958%$397.73M+9,872%-$4.07M+92.6%-$55.1M+29.0%-$77.55M-98.8%
Price / book3.6×+3.2×3.7×+2.7×+0.4×0.5×+0.1×0.4×-0.3×
Free cash flow yield-7.1%+83.0pp-9.4%+40.1pp-49.4%+34.2pp-83.7%+10.2pp-93.8%-50.4pp
Earnings yield-8.4%+95.4pp-11.4%+45.8pp-57.2%+38.6pp-95.8%+12.2pp-108%-54.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Alto Neuroscience's ratios come from?
Every ratio is computed from Alto Neuroscience's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.